# IrisVision Global

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/irisvision-global

- Industry: Medical Devices & Equipment
- Headquarters: Pleasanton, US
- Website: www.irisvision.com
- Latest round: Seed (Apr 18, 2019)
- Investors on record: 3

## About

IrisVision Global, Inc. is a technology firm focused on developing innovative wearable devices that empower individuals with low vision to regain independence in their daily activities.IrisVision Global, Inc. specializes in creating advanced wearable technologies for people with vision impairments. Founded by Frank Werblin, the company is headquartered in Pleasanton, US. They raised venture funding in April 2019 from investors including HealthTech Capital, Joyance Partners, and Social Starts. The firm has been involved in one deal since its inception.IrisVision develops and distributes the IrisVision LIVE 2.0, an advanced wearable device for individuals with low vision. This device uses augmented reality technology to enhance visual capacity for conditions such as Macular Degeneration and Diabetic Retinopathy. It enables users to engage in daily activities like reading and watching television independently, offering customizable vision modes and a high-resolution display. The products are sold directly to customers across various markets, including the United States, Canada, and select countries in Europe and Asia.IrisVision operates on a direct-to-consumer model, allowing customers to purchase the IrisVision LIVE 2.0 and related accessories through their online platform. Their revenue comes primarily from individual product sales, complemented by a one-year warranty and personalized training support. A 30-day evaluation period for product returns builds consumer trust. The company aims to make its technology accessible through competitive pricing and promotions, addressing the growing demand for assistive technologies as the population ages.IrisVision's strategy for growth includes the launch of new product versions and enhancements to the IrisVision LIVE 2.0. The recent funding from April 2019 will support these initiatives and facilitate expansion into new markets, particularly targeted regions in Europe and Asia, by 2023. The investment aims to bolster their capabilities in R&D and market penetration, aligning with the rising demand for assistive technology.

## Funding rounds

- Seed, Apr 18, 2019 — HealthTech Capital, Social Starts, Joyance Partners

## Investors

- HealthTech Capital — Seed
- Social Starts (https://capitalatlas.ai/funds/social-starts) — Seed
- Joyance Partners (https://capitalatlas.ai/funds/joyance-partners) — Seed